Impact of more detailed categorization of shrinkage or progression ratio at initial imaging response after sorafenib treatment in advanced hepatocellular carcinoma patients

BACKGROUND: Sorafenib therapy improves survival in unresectable hepatocellular carcinoma (HCC) patients without an objective response. The present study investigated whether the initial imaging response might be a prognostic indicator after administration of sorafenib therapy in HCC patients. PATIEN...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Yoshiyuki, Takami, Yuko, Tateishi, Masaki, Ryu, Tomoki, Mikagi, Kazuhiro, Saitsu, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636094/
https://www.ncbi.nlm.nih.gov/pubmed/26586953
http://dx.doi.org/10.2147/OTT.S94246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636094/
https://www.ncbi.nlm.nih.gov/pubmed/26586953
http://dx.doi.org/10.2147/OTT.S94246

Ejemplares similares